HEXO to participate in Cowen’s 4th Annual Cannabis Conference
11/24/2021 - 06:30 AM
OTTAWA, Nov. 24, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NASDAQ: HEXO) today announced that management will attend Cowen’s 4th Annual Cannabis Conference on November 30, 2021. Valerie Malone, Chief Commercial Officer, will participate in the “Canadian Cannabis: The Adult Use Landscape” panel at 10:10 a.m. ET.
Management will be available for virtual one-on-one meetings with institutional and corporate clients of the firm. COWEN hosted events are intended for prospective and existing COWEN clients and management participants only. To listen to the live event or request 1-on-1 meetings with the Company, please contact your Cowen representative with interest.
About HEXO
HEXO is an award-winning licensed producer of innovative products for the global cannabis market. HEXO serves the Canadian recreational market with a brand portfolio including HEXO, Redecan, UP Cannabis, Namaste, Original Stash, Trail Mix, 48North, Bake Sale, REUP and Latitude brands, and the medical market in Canada, Australia, Israel and Malta. The Company also serves the Colorado market through its Powered by HEXO® strategy and Truss CBD USA, a joint venture with Molson-Coors. With the completion of HEXO's recent acquisitions of Redecan and 48North, HEXO is a leading cannabis products company in Canada by recreational market share. For more information, please visit hexocorp.com.
Investor Relations:
invest@hexo.com
www.hexocorp.com
(819) 317-0526
media@hexo.com
HEXO Rankings
N/A Ranked by Stock Gains
HEXO Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Pharmaceuticals: Other, Health Technology, Process Industries, Agricultural Commodities/Milling, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
Canada
City
Ottawa
About HEXO
hydropothecary est un producteur agréé et distributeur de marijuana médicale en vertu du règlement sur l'accès aux cannabis pour fins médicales (racfm) de santé canada. nous sommes voués à l’excellence médicale et excellons dans nos techniques de culture, les contrôles des processus, les tests d’assurance-qualité, les activités de recherche et développement et l’offre d’un service à la clientèle exceptionnel. nous sommes fiers de la croissance remarquable de notre entreprise jusqu’à présent et anticipons grandement la continuation de cette expansion avec l’ajout d’une serre de 250 000 pieds carrés supplémentaires en 2018. nous sommes constamment à la recherche de professionnels talentueux, énergiques et hautement spécialisés pour joindre notre équipe et faire partie d'une industrie passionnante en évolution continue. ------------ the hydropothecary is a licensed producer and distributor of medical marijuana under health canada’s access to cannabis for medical purposes regulations (acmp
